We provide you with 20 years of free, institutional-grade data for TPST stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TPST. Explore the full financial landscape of TPST stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about TPST stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Tempest Therapeutics Inc(NASDAQ:TPST) 
Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company is headquartered in South San Francisco, California.
Website: https://www.tempesttx.com/
Founded: 2011
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Share this website to your friends